Close

Beta-Blocker

Beta-Blocker Reduces Lung Inflammation in Critical COVID-19

In a small study, intravenous administration of the beta-blocker metoprolol to critically ill COVID-19 patients with acute respiratory distress syndrome (ARDS) safely blunted lung inflammation associated with the disease. Metoprolol administration also resulted in better oxygenation and fewer days on intensive mechanical ventilation (IMV) and in the intensive care unit (ICU), compared with no treatment. These […]

Read More